- Home
- REPL vs ITRN Comparison
REPL vs ITRN Comparison
Compare REPL & ITRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- REPL
- ITRN
- Stock Information
- Founded
- REPL 2015
- ITRN 1994
- Country
- REPL United States
- ITRN Israel
- Employees
- REPL N/A
- ITRN N/A
- Industry
- REPL Biotechnology: Pharmaceutical Preparations
- ITRN Electronic Components
- Sector
- REPL Health Care
- ITRN Technology
- Exchange
- REPL Nasdaq
- ITRN Nasdaq
- Market Cap
- REPL 578.4M
- ITRN 653.7M
- IPO Year
- REPL 2018
- ITRN 2005
- Fundamental
- Price
- REPL $8.98
- ITRN $38.09
- Analyst Decision
- REPL Strong Buy
- ITRN Buy
- Analyst Count
- REPL 6
- ITRN 1
- Target Price
- REPL $20.00
- ITRN $50.00
- AVG Volume (30 Days)
- REPL 1.6M
- ITRN 80.9K
- Earning Date
- REPL 05-22-2025
- ITRN 05-28-2025
- Dividend Yield
- REPL N/A
- ITRN 5.25%
- EPS Growth
- REPL N/A
- ITRN 10.62
- EPS
- REPL N/A
- ITRN 2.77
- Revenue
- REPL N/A
- ITRN $337,686,000.00
- Revenue This Year
- REPL N/A
- ITRN $11.52
- Revenue Next Year
- REPL N/A
- ITRN $9.29
- P/E Ratio
- REPL N/A
- ITRN $13.76
- Revenue Growth
- REPL N/A
- ITRN 3.73
- 52 Week Low
- REPL $4.93
- ITRN $24.12
- 52 Week High
- REPL $17.00
- ITRN $45.43
- Technical
- Relative Strength Index (RSI)
- REPL 53.81
- ITRN 58.13
- Support Level
- REPL $8.25
- ITRN $35.06
- Resistance Level
- REPL $9.53
- ITRN $39.37
- Average True Range (ATR)
- REPL 0.88
- ITRN 1.22
- MACD
- REPL 0.17
- ITRN 0.02
- Stochastic Oscillator
- REPL 71.10
- ITRN 70.19
About REPL Replimune Group Inc.
Replimune Group Inc is a clinical-stage biotechnology company. It uses a proprietary RPx platform to design and develop product candidates that are intended to maximally activate the immune system against solid tumors. The RPx platform is based on a proprietary, engineered strain of herpes simplex virus 1, or HSV-1, backbone with payloads added to maximize immunogenic cell death and the induction of a systemic anti-tumor immune response. The company focuses on developing oncolytic immunotherapies for the treatment of cancer. Its pipeline products include RP1, RP2, and RP3.
About ITRN Ituran Location and Control Ltd.
Ituran Location and Control Ltd is a provider of location-based services. The company operates in two segments, namely Telematics services, and Telematics products. The Telematics services segment consists of regionally- based stolen vehicle recovery (SVR) services, fleet management services, and value-added services comprised of personal locater services and concierge services. The Telematics product segment consists of short and medium-range two-way machine-to-machine wireless communications products that are used for various applications, including automatic vehicle location, and automatic vehicle identification. Its geographical segments include Israel, Brazil, and Others.